Suppr超能文献

[墨西哥四个皮肤科中心引起甲癣的酵母菌及其对唑类化合物的抗真菌药敏性]

[Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].

作者信息

Manzano-Gayosso Patricia, Méndez-Tovar Luis Javier, Arenas Roberto, Hernández-Hernández Francisca, Millán-Chiu Blanca, Torres-Rodríguez Josep M, Cortés-González Elda, Fernández Ramón, López-Martínez Rubén

机构信息

Laboratorio de Micología Médica, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, México.

出版信息

Rev Iberoam Micol. 2011 Jan-Mar;28(1):32-5. doi: 10.1016/j.riam.2010.11.002. Epub 2010 Dec 13.

Abstract

BACKGROUND

Yeasts represent the second cause of nail fungal infection in the world, and Candida albicans and Candida parapsilosis are the two most common species.

OBJECTIVES

To determine the yeast species frequency and their in vitro antifungal susceptibility, obtained from patients with clinical features suggestive of onychomycosis.

METHODS

A prospective study was carried out in four dermatological care centers in Mexico from 2004 to 2007. Clinical diagnosis was corroborated by direct examination and culture. The yeast species was determined by morphological and biochemical tests. An antifungal susceptibility test to ketoconazole, itraconazole and fluconazole by the broth microdilution method was performed on each isolate (document M27-A2).

RESULTS

One hundred sixty-six yeast isolates were obtained; the most frequently found species were C. parapsilosis (31.9%), C. albicans (22.4%) and Candida guilliermondii (12.7%). Of all isolates, 51 showed resistance to one or several of the azole compounds: 33 to itraconazole, 12 to ketoconazole and 6 to fluconazole. It was remarkable that the four Candida glabrata isolates were resistant to the three azole compounds; C. guilliermondii and Candida famata were resistant to itraconazole in 42.9% and 54.5%, respectively.

CONCLUSION

The results obtained show the importance of identifying the aetiological agent and antifungal susceptibility testing in order to avoid therapeutic failures in onychomycosis.

摘要

背景

酵母菌是全球指甲真菌感染的第二大病因,白色念珠菌和近平滑念珠菌是最常见的两种菌种。

目的

确定从有甲真菌病临床症状的患者中分离出的酵母菌菌种频率及其体外抗真菌药敏情况。

方法

2004年至2007年在墨西哥的四个皮肤科护理中心开展了一项前瞻性研究。通过直接检查和培养来证实临床诊断。通过形态学和生化试验确定酵母菌菌种。采用肉汤微量稀释法(文件M27 - A2)对每个分离株进行酮康唑、伊曲康唑和氟康唑的抗真菌药敏试验。

结果

共获得166株酵母菌分离株;最常见的菌种是近平滑念珠菌(31.9%)、白色念珠菌(22.4%)和季也蒙念珠菌(12.7%)。在所有分离株中,51株对一种或几种唑类化合物耐药:33株对伊曲康唑耐药,12株对酮康唑耐药,6株对氟康唑耐药。值得注意的是,4株光滑念珠菌分离株对三种唑类化合物均耐药;季也蒙念珠菌和法马念珠菌对伊曲康唑的耐药率分别为42.9%和54.5%。

结论

所得结果表明,为避免甲真菌病治疗失败,鉴定病原体和进行抗真菌药敏试验具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验